<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/rhythm-shares-jump-on-reported-astrazeneca-bid</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T14:05:16.601Z</news:publication_date>
      <news:title>Rhythm Shares Jump 28% on Reported AstraZeneca Takeover Bid</news:title>
      <news:keywords>AstraZeneca, Rhythm Pharmaceuticals, M&amp;A, Obesity, Rare disease</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/lonza-to-buy-5-us-plants-from-merck-kgaa</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T07:58:45.931Z</news:publication_date>
      <news:title>Lonza to Buy 5 US Plants From Merck KGaA, Adding About 1,100 Staff</news:title>
      <news:keywords>Lonza, Merck KGaA, CDMO, manufacturing, antibody-drug conjugates</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/uw-madison-62m-cyclotron-lab-isotope-output</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T14:06:32.980Z</news:publication_date>
      <news:title>UW-Madison&apos;s $62M Cyclotron Lab Aims to Lift Isotope Output Up to 8x</news:title>
      <news:keywords>cyclotron, medical isotopes, astatine-211, theranostics, Wisconsin</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/fda-approves-jj-rybrevant-faspro-head-and-neck-cancer</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T07:57:47.920Z</news:publication_date>
      <news:title>FDA Approves J&amp;J Head and Neck Cancer Shot After 42% Respond</news:title>
      <news:keywords>FDA, Johnson &amp; Johnson, amivantamab, head and neck cancer, accelerated approval</news:keywords>
    </news:news>
  </url>
</urlset>